- Home
- / Capella BioScience
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Capella BioScience financials data including stock price, CreditSafe score, and balance sheet.
Total Funding
$15.5 M
CreditSafe Score
?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| GBP | FY, 2016 | FY, 2017 | FY, 2018 |
|---|---|---|---|
| Cash | 2.6M | 807.1K | 4.8M |
| Current Assets | 3.1M | 1.4M | 5.7M |
| PP&E | 339.0 | 1.1K | 643.0 |
| Total Assets | 3.1M | 1.4M | 5.7M |
| Accounts Payable | 97.7K | 282.7K | 279.3K |
| Current Liabilities | 254.1K | 493.3K | 647.9K |
| Long-term Debt | 1.3M | 1.5M | 3.4M |
| Non-Current Liabilities | 1.3M | 1.5M | 3.4M |
| Total Debt | 1.3M | 1.5M | 3.4M |
| Total Liabilities | 1.5M | 2.0M | 4.0M |
| Common Stock | 3.4K | 3.4K | 7.3K |
| Retained Earnings | (2.2M) | (4.2M) | (7.9M) |
| Total Equity | 1.6M | (564.6K) | 1.7M |
| Financial Leverage | 2 | -2.5 | 3.4 |